小智港股覆盤 | 12月19日
今日，港股三大指數集體下跌。截止收盤，恆生指數跌0.5%，報19352點。國企指數跌0.45%，報6604點。恆生科技指數跌0.58%，報4125點。市場約512只個股上漲，1118只個股下跌。成交額突破1006.65億港幣，和昨天同期相比下跌26.0%。南下資金淨流出4.27億港幣。
盤面上，綜合消費服務板塊全線走強。光正教育漲超52%；澳洲成峯高教漲超19%；新高教集團漲超15%；成實外教育、嘉宏教育等多股漲超13%。光正教育漲超29%領漲教育板塊，擴大內需綱要重提支持民辦教育，機構看好明年教育板塊修復空間；新高教集團升7%，月內回購+創始人增持，申萬料其未來三年收入複合年增長8%；成實外教育升60%，月內高管增持近40萬股，22財年扭虧爲盈；嘉宏教育漲超11%領漲教育板塊，機構看好明年板塊修復空間。
綜合金融服務板塊跟隨走強。亞洲資源漲超25%；東銀國際控股漲超7%；紫元元漲超6%；山高控股漲超5%；盛業漲超4%。
電力板塊活躍。港燈-SS漲超3%；中電控股漲超2%；長江基建集團漲超1%。
海運板塊暴跌。海豐國際跌超15%；東方海外國際跌超9%；勇利投資跌超8%；太平洋航運跌超6%；珠江船務跌超5%。部分物流股隨市上揚，海豐國際高漲9.73%；恆生指數收漲0.42%報19450點，教育股及航運股強勢，東方海外國際漲8.70%領漲藍籌；太平洋航運：購回本金總額爲1050萬美元的可換股債券。
互聯網醫療板塊全線走低。醫脈通跌超9%；阿裏健康跌超8%；平安好醫生跌超6%；鷹瞳科技-B、醫渡科技等多股跌超4%。醫脈通放量升29%，公司迴應股價波動，逾80%中國執業醫生爲公司平臺用戶；菜鳥再增派6批快遞員援京，對阿裏健康防護用品及生活物資優先配送；中信證券：維持平安好醫生“買入”評級，目標價32港元；醫渡科技漲近25%，互聯網診療助力疫情防控，公司估值有望提升。
生物科技板塊多數下跌。三葉草生物-B跌超15%；君實生物跌超14%；雲頂新耀-B、開拓藥業-B、永泰生物-B等多股跌超8%。三葉草生物-B完成配售1.28億股，預計所得款項淨額5億港元；君實生物升7%，公司指正探索VV116全球市場註冊及商業化。
uSMART智能寫手的信息、數據均來自媒體公開報道，智能寫手不能保證其完全準確，內容僅供參考，不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
